Landing
The Great Life Science Reset: Why the “Sick Care” Model is Failing
The data reveals a significant transition: the end of the traditional sick care model and the rise of a proactive healthcare ecosystem. Learn how smart money is utilising AI to cut drug discovery times in half, transform diagnostics to detect complex diseases in days, and create efficiencies to scale the healthcare system without a proportional increase in costs.
Anthropic Economic Index: Why the “Skills Gap” is About to Explode
The latest Anthropic Economic Index warns that AI is not a leveller for junior staff but a force multiplier for senior engineers, accelerating the skills gap. The transition requires a focus on workflow design and redesigning roles around where the 12x leverage actually exists.
The Bridge Is Built: Why the NYSE’s Move Changes Capital Allocation Forever
The New York Stock Exchange has fundamentally changed the future of finance by announcing a dedicated platform for the trading and on-chain settlement of tokenised securities. This pivotal move signals the institutionalisation of digital assets, bringing 24/7 operations, instant (T+0) settlement, and new advantages for private wealth allocators.
Why Life Sciences Is Now One of My Highest Conviction Investment Themes
In 17 years, we’ve watched themes rise and fall. Today, life sciences is a portfolio-defining opportunity. This is not speculation; it is pattern recognition based on the staggering returns from companies like Telix and Neuren, and the convergence of AI, clear regulatory pathways, and a shift in capital back toward real science.
The GPS for Oncology: Ending the era of ‘blind’ cancer removal
Ferronova is pioneering the “GPS for Oncology” with magnetic nanoparticles, creating a high-definition roadmap to precisely trace cancer in lymph nodes and eliminate the guesswork of traditional surgery, a move from “search and destroy” to “trace and target.”
The Shift: Why Big Tech Stopped Buying Companies and Started Buying Brains
The unprecedented speed of AI innovation has triggered a structural shift in how Big Tech consolidates power. The era of the full company acquisition is pausing, replaced by a new model: buying brains and renting IP through rapid, high-value licensing deals and surgical talent extraction that sidesteps regulatory hurdles.
The Convergence: Why AI and Life Sciences are the Next Trillion-Dollar Frontier
The global healthcare model is undergoing a fundamental economic transition, moving from expensive ‘Sickcare’ to proactive ‘Lifecare.’ This shift is powered by the convergence of artificial intelligence and the industrialisation of biology, creating massive, compelling investment opportunities in infrastructure and redefining the future of health.
The Private Equity Shift: What Smart Money is Positioning For in 2026
Private equity is now the priority allocation target for institutions in 2026. This fundamental shift is driven by a convergence of technology and demographic changes, creating four major investment trends: the democratisation of access, the succession supercycle, the rise of sports as an asset class, and AI-driven operational improvement.
The “Crypto Cycle” is Dead. The Infrastructure Era is Here.
The digital asset market is transitioning from an era of speculation to institutionalisation. The traditional “4-year Halving Cycle” is broken, as smart money focuses on building the rails for the future of finance, driven by Macro Liquidity, Real World Assets (RWA) tokenisation, and Stablecoins as the global settlement layer.
Backed By Leading Investment Groups and Family Offices
